Category: 114834-02-5

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Sengmany, Stephane; Le Gall, Erwan; Leonel, Eric researched the compound: 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine( cas:114834-02-5 ).Application In Synthesis of 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine.They published the article 《An electrochemical synthesis of functionalized arylpyrimidines from 4-amino-6-chloropyrimidines and aryl halides》 about this compound( cas:114834-02-5 ) in Molecules. Keywords: aminochloropyrimidine aryl halide electrochem cross coupling nickel catalyst; biaryl heteroaryl preparation. We’ll tell you more about this compound (cas:114834-02-5).

A range of novel 4-amino-6-arylpyrimidines was prepared under mild conditions by an electrochem. reductive cross-coupling between 4-amino-6-chloro-pyrimidines and functionalized aryl halides. The process, which employed a sacrificial iron anode in conjunction with a nickel(II) catalyst, allows the formation of coupling products in moderate to high yields.

After consulting a lot of data, we found that this compound(114834-02-5)Application In Synthesis of 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine can be used in many types of reactions. And in most cases, this compound has more advantages.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Heterocyclic compounds can be divided into two categories: alicyclic heterocycles and aromatic heterocycles. Compounds whose heterocycles in the molecular skeleton cannot reflect aromaticity are called alicyclic heterocyclic compounds. Compound: 114834-02-5, is researched, Molecular C7H5ClN4, about Synthesis and cytoprotective antiulcer activity of 2- or 4-(1H-pyrazol-1-yl)pyrimidine derivatives related to mepirizole and dulcerozine, the main research direction is pyrimidine pyrazolyl imidazolyl triazolyl antiulcer cytoprotective; mepirizole derivative preparation antiulcer cytoprotective; dulcerozine derivative preparation antiulcer cytoprotective.Quality Control of 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine.

A variety of (1H-pyrazol-1-yl)-, (1H-imidazol-1-yl)-, and (1H-1,2,4,-triazol-1-yl)pyrimidines were prepared and evaluated for cytoprotective antiulcer activity. The compounds include members of structures I [R = pyrazol-1-yl, 3-methylpyrazol-1-yl, imidazol-1-yl, 1,2,4-triazol-1-yl; R1 = H, OMe, OEt; R2 = H, Me] and II [R = pyrazol-1-yl, imidazol-1-yl; R1 = OMe, OEt, OPh, NH2, NHMe, pyrrolidino, piperidino, H, SMe, etc.]. Among them, 4-methoxy-6-methyl-2-(1H-pyrazol-1-yl)pyrimidine (III) showed potent inhibition of HCl-EtOH-induced and water-immersion stress-induced ulcers in rats, as well as low acute toxicity.

Although many compounds look similar to this compound(114834-02-5)Quality Control of 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine, numerous studies have shown that this compound(SMILES:ClC1=NC=NC(N2C=CN=C2)=C1), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

COA of Formula: C7H5ClN4. Aromatic compounds can be divided into two categories: single heterocycles and fused heterocycles. Compound: 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine, is researched, Molecular C7H5ClN4, CAS is 114834-02-5, about Selective mono-amination of dichlorodiazines. Author is Sengmany, Stephane; Lebre, Julie; Le Gall, Erwan; Leonel, Eric.

3,6-Dichloropyridazine, 4,6-dichloropyrimidine, 2,4-dichloropyrimidine, and 3,5-dichloropyridazine underwent chemoselective monosubstitution reactions with amines using triethylamine as a base in ethanol at either ambient temperature or reflux to give monoamino monochloro pyridazines and pyrimidines. The methodol. is general and efficient despite noticeable differences in reactivity between diazines; while dichloropyridazine and dichloropyrazine require several hours of heating at reflux for the reaction to proceed, dichloropyrimidines reach completion within minutes at room temperature

Although many compounds look similar to this compound(114834-02-5)COA of Formula: C7H5ClN4, numerous studies have shown that this compound(SMILES:ClC1=NC=NC(N2C=CN=C2)=C1), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Synthetic Route of C7H5ClN4. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine, is researched, Molecular C7H5ClN4, CAS is 114834-02-5, about BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia. Author is King, Dalton; Iwuagwu, Christiana; Cook, Jim; McDonald, Ivar M.; Mate, Robert; Zusi, F. Christopher; Hill, Matthew D.; Fang, Haiquan; Zhao, Rulin; Wang, Bei; Easton, Amy E.; Miller, Regina; Post-Munson, Debra; Knox, Ronald J.; Gallagher, Lizbeth; Westphal, Ryan; Molski, Thaddeus; Fan, Jingsong; Clarke, Wendy; Benitex, Yulia; Lentz, Kimberley A.; Denton, Rex; Morgan, Daniel; Zaczek, Robert; Lodge, Nicholas J.; Bristow, Linda J.; Macor, John E.; Olson, Richard E..

The therapeutic treatment of neg. symptoms and cognitive dysfunction associated with schizophrenia is a significant unmet medical need. Preclin. literature indicates that α7 neuronal nicotinic acetylcholine (nACh) receptor agonists may provide an effective approach to treating cognitive dysfunction in schizophrenia. The authors report herein the discovery and evaluation of I (BMS-933043), a novel and potent α7 nACh receptor partial agonist with high selectivity against other nicotinic acetylcholine receptor subtypes (>100-fold) and the 5-HT3A receptor (>300-fold). In vivo activity was demonstrated in a preclin. model of cognitive impairment, mouse novel object recognition. BMS-933043 has completed Phase I clin. trials.

As far as I know, this compound(114834-02-5)Synthetic Route of C7H5ClN4 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Formula: C7H5ClN4. The reaction of aromatic heterocyclic molecules with protons is called protonation. Aromatic heterocycles are more basic than benzene due to the participation of heteroatoms. Compound: 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine, is researched, Molecular C7H5ClN4, CAS is 114834-02-5, about An electrochemical synthesis of functionalized arylpyrimidines from 4-amino-6-chloropyrimidines and aryl halides. Author is Sengmany, Stephane; Le Gall, Erwan; Leonel, Eric.

A range of novel 4-amino-6-arylpyrimidines was prepared under mild conditions by an electrochem. reductive cross-coupling between 4-amino-6-chloro-pyrimidines and functionalized aryl halides. The process, which employed a sacrificial iron anode in conjunction with a nickel(II) catalyst, allows the formation of coupling products in moderate to high yields.

In addition to the literature in the link below, there is a lot of literature about this compound(4-Chloro-6-(1H-imidazol-1-yl)pyrimidine)Formula: C7H5ClN4, illustrating the importance and wide applicability of this compound(114834-02-5).

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Related Products of 114834-02-5. The reaction of aromatic heterocyclic molecules with protons is called protonation. Aromatic heterocycles are more basic than benzene due to the participation of heteroatoms. Compound: 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine, is researched, Molecular C7H5ClN4, CAS is 114834-02-5, about BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia. Author is King, Dalton; Iwuagwu, Christiana; Cook, Jim; McDonald, Ivar M.; Mate, Robert; Zusi, F. Christopher; Hill, Matthew D.; Fang, Haiquan; Zhao, Rulin; Wang, Bei; Easton, Amy E.; Miller, Regina; Post-Munson, Debra; Knox, Ronald J.; Gallagher, Lizbeth; Westphal, Ryan; Molski, Thaddeus; Fan, Jingsong; Clarke, Wendy; Benitex, Yulia; Lentz, Kimberley A.; Denton, Rex; Morgan, Daniel; Zaczek, Robert; Lodge, Nicholas J.; Bristow, Linda J.; Macor, John E.; Olson, Richard E..

The therapeutic treatment of neg. symptoms and cognitive dysfunction associated with schizophrenia is a significant unmet medical need. Preclin. literature indicates that α7 neuronal nicotinic acetylcholine (nACh) receptor agonists may provide an effective approach to treating cognitive dysfunction in schizophrenia. The authors report herein the discovery and evaluation of I (BMS-933043), a novel and potent α7 nACh receptor partial agonist with high selectivity against other nicotinic acetylcholine receptor subtypes (>100-fold) and the 5-HT3A receptor (>300-fold). In vivo activity was demonstrated in a preclin. model of cognitive impairment, mouse novel object recognition. BMS-933043 has completed Phase I clin. trials.

In addition to the literature in the link below, there is a lot of literature about this compound(4-Chloro-6-(1H-imidazol-1-yl)pyrimidine)Related Products of 114834-02-5, illustrating the importance and wide applicability of this compound(114834-02-5).

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Most of the natural products isolated at present are heterocyclic compounds, so heterocyclic compounds occupy an important position in the research of organic chemistry. A compound: 114834-02-5, is researched, SMILESS is ClC1=NC=NC(N2C=CN=C2)=C1, Molecular C7H5ClN4Journal, Article, Chemical & Pharmaceutical Bulletin called Synthesis and cytoprotective antiulcer activity of 2- or 4-(1H-pyrazol-1-yl)pyrimidine derivatives related to mepirizole and dulcerozine, Author is Ikeda, Masazumi; Maruyama, Kazumi; Nobuhara, Youichi; Yamada, Toshihiro; Okabe, Susumu, the main research direction is pyrimidine pyrazolyl imidazolyl triazolyl antiulcer cytoprotective; mepirizole derivative preparation antiulcer cytoprotective; dulcerozine derivative preparation antiulcer cytoprotective.HPLC of Formula: 114834-02-5.

A variety of (1H-pyrazol-1-yl)-, (1H-imidazol-1-yl)-, and (1H-1,2,4,-triazol-1-yl)pyrimidines were prepared and evaluated for cytoprotective antiulcer activity. The compounds include members of structures I [R = pyrazol-1-yl, 3-methylpyrazol-1-yl, imidazol-1-yl, 1,2,4-triazol-1-yl; R1 = H, OMe, OEt; R2 = H, Me] and II [R = pyrazol-1-yl, imidazol-1-yl; R1 = OMe, OEt, OPh, NH2, NHMe, pyrrolidino, piperidino, H, SMe, etc.]. Among them, 4-methoxy-6-methyl-2-(1H-pyrazol-1-yl)pyrimidine (III) showed potent inhibition of HCl-EtOH-induced and water-immersion stress-induced ulcers in rats, as well as low acute toxicity.

I hope my short article helps more people learn about this compound(4-Chloro-6-(1H-imidazol-1-yl)pyrimidine)HPLC of Formula: 114834-02-5. Apart from the compound(114834-02-5), you can read my other articles to know other related compounds.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine( cas:114834-02-5 ) is researched.Formula: C7H5ClN4.King, Dalton; Iwuagwu, Christiana; Cook, Jim; McDonald, Ivar M.; Mate, Robert; Zusi, F. Christopher; Hill, Matthew D.; Fang, Haiquan; Zhao, Rulin; Wang, Bei; Easton, Amy E.; Miller, Regina; Post-Munson, Debra; Knox, Ronald J.; Gallagher, Lizbeth; Westphal, Ryan; Molski, Thaddeus; Fan, Jingsong; Clarke, Wendy; Benitex, Yulia; Lentz, Kimberley A.; Denton, Rex; Morgan, Daniel; Zaczek, Robert; Lodge, Nicholas J.; Bristow, Linda J.; Macor, John E.; Olson, Richard E. published the article 《BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia》 about this compound( cas:114834-02-5 ) in ACS Medicinal Chemistry Letters. Keywords: BMS933043 alpha7 nAChR agonist cognition enhancer antipsychotic schizophrenia; Schizophrenia; clinical candidate; quinuclidine; α7 nAChR partial agonist; α7 neuronal nicotinic acetylcholine receptor. Let’s learn more about this compound (cas:114834-02-5).

The therapeutic treatment of neg. symptoms and cognitive dysfunction associated with schizophrenia is a significant unmet medical need. Preclin. literature indicates that α7 neuronal nicotinic acetylcholine (nACh) receptor agonists may provide an effective approach to treating cognitive dysfunction in schizophrenia. The authors report herein the discovery and evaluation of I (BMS-933043), a novel and potent α7 nACh receptor partial agonist with high selectivity against other nicotinic acetylcholine receptor subtypes (>100-fold) and the 5-HT3A receptor (>300-fold). In vivo activity was demonstrated in a preclin. model of cognitive impairment, mouse novel object recognition. BMS-933043 has completed Phase I clin. trials.

Here is a brief introduction to this compound(114834-02-5)Formula: C7H5ClN4, if you want to know about other compounds related to this compound(114834-02-5), you can read my other articles.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

The chemical properties of alicyclic heterocycles are similar to those of the corresponding chain compounds. Compound: 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine, is researched, Molecular C7H5ClN4, CAS is 114834-02-5, about Selective mono-amination of dichlorodiazines, the main research direction is amino chloro pyridazine pyrimidine chemoselective preparation; chemoselective monosubstitution dichloropyridazine dichloropyrimidine amine triethylamine ethanol; kinetics relative reactivity chemoselective monosubstitution dichloropyridazine dichloropyrimidine morpholine.Synthetic Route of C7H5ClN4.

3,6-Dichloropyridazine, 4,6-dichloropyrimidine, 2,4-dichloropyrimidine, and 3,5-dichloropyridazine underwent chemoselective monosubstitution reactions with amines using triethylamine as a base in ethanol at either ambient temperature or reflux to give monoamino monochloro pyridazines and pyrimidines. The methodol. is general and efficient despite noticeable differences in reactivity between diazines; while dichloropyridazine and dichloropyrazine require several hours of heating at reflux for the reaction to proceed, dichloropyrimidines reach completion within minutes at room temperature

Compound(114834-02-5)Synthetic Route of C7H5ClN4 received a lot of attention, and I have introduced some compounds in other articles, similar to this compound(4-Chloro-6-(1H-imidazol-1-yl)pyrimidine), if you are interested, you can check out my other related articles.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Ikeda, Masazumi; Maruyama, Kazumi; Nobuhara, Youichi; Yamada, Toshihiro; Okabe, Susumu published the article 《Synthesis and cytoprotective antiulcer activity of 2- or 4-(1H-pyrazol-1-yl)pyrimidine derivatives related to mepirizole and dulcerozine》. Keywords: pyrimidine pyrazolyl imidazolyl triazolyl antiulcer cytoprotective; mepirizole derivative preparation antiulcer cytoprotective; dulcerozine derivative preparation antiulcer cytoprotective.They researched the compound: 4-Chloro-6-(1H-imidazol-1-yl)pyrimidine( cas:114834-02-5 ).COA of Formula: C7H5ClN4. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:114834-02-5) here.

A variety of (1H-pyrazol-1-yl)-, (1H-imidazol-1-yl)-, and (1H-1,2,4,-triazol-1-yl)pyrimidines were prepared and evaluated for cytoprotective antiulcer activity. The compounds include members of structures I [R = pyrazol-1-yl, 3-methylpyrazol-1-yl, imidazol-1-yl, 1,2,4-triazol-1-yl; R1 = H, OMe, OEt; R2 = H, Me] and II [R = pyrazol-1-yl, imidazol-1-yl; R1 = OMe, OEt, OPh, NH2, NHMe, pyrrolidino, piperidino, H, SMe, etc.]. Among them, 4-methoxy-6-methyl-2-(1H-pyrazol-1-yl)pyrimidine (III) showed potent inhibition of HCl-EtOH-induced and water-immersion stress-induced ulcers in rats, as well as low acute toxicity.

There is still a lot of research devoted to this compound(SMILES：ClC1=NC=NC(N2C=CN=C2)=C1)COA of Formula: C7H5ClN4, and with the development of science, more effects of this compound(114834-02-5) can be discovered.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider